Surgery for hepatic neuroendocrine tumors: A single institutional experience in Japan

Japanese Journal of Clinical Oncology

Volumn 37, Issue 2, 2007, Pages 102-107

  Hibi, Taizo ^a   Sano, Tsuyoshi ^a   Sakamoto, Yoshihiro ^a   Takahashi, Yu ^a   Uemura, Norihisa ^b   Ojima, Hidenori ^b   Shimada, Kazuaki ^a   Kosuge, Tomoo ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Hepatectomy; Neoplasm metastasis; Neuroendocrine tumors

Indexed keywords

ADULT; AGED; ARTICLE; ASIA; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FOLLOW UP; HUMAN; JAPAN; JAPANESE; LIVER METASTASIS; LIVER RESECTION; LIVER TUMOR; LUNG CANCER; MALE; MEDICAL RECORD REVIEW; NEUROENDOCRINE TUMOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PROGNOSIS; RETROSPECTIVE STUDY; SURGICAL APPROACH; SURGICAL MORTALITY; SURVIVAL RATE;

ADULT; AGED; FEMALE; HEPATECTOMY; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; SURVIVAL ANALYSIS;

EID: 34250881497     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyl140     Document Type: Article

References (28)

1. Sutcliffe R, Maguire D, Ramage J, Rela M, Heaton N. Management of neuroendocrine liver metastases. Am J Surg 2004;187:39-46.
2. Que FG, Sarmiento JM, Nagorney DM. Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors. Cancer Control 2002;9:67-79.
3. Öberg K. Carcinoid tumors: Current concepts in diagnosis and treatment. Oncologist 1998;3:339-45.
4. Touzios JG, Kiely JM, Pitt SC, Rilling WS, Quebbeman EJ, Wilson SD, et al. Neuroendocrine hepatic metastases. Does aggressive management improve survival? Ann Surg 2005;241:776-85.
5. Jaeck D, Oussoultzoglou E, Bachellier P, Lemarque P, Weber JC, Nakano H, et al. Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: Safe hepatic surgery. World J Surg 2001; 25:689-92.
6. Nave H, Mössinger E, Feist H, Lang H, Raab HR. Surgery as primary treatment in patients with liver metastases from carcinoid tumors: A retrospective, unicentric study over 13 years. Surgery 2001;129:170-5.
7. Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995; 169:36-43.
8. Ahlman H, Westberg G, Wängberg B, Nilsson O, Tylén U, Scherstén T, et al. Treatment of liver metastases of carcinoid tumors. World J Surg 1996;20:196-202.
9. Chen H, Hardacre JM, Uzar A, Cameron JL, Choti MA. Isolated liver metastases from neuroendocrine tumors: Does resection prolong survival? J Am Coll Surg 1998;187:88-93.
10. Chamberlain RS, Canes D, Brown KT, Saltz L, Jarnagin W, Fong Y, et al. Hepatic neuroendocrine metastases: Does intervention alter outcomes? J Am Coll Surg 2000;190:432-45.
11. Grazi GL, Cescon M, Pierangeli F, Ercolani G, Gardini A, Cavallari A, et al. Highly aggressive policy of hepatic resections for neuroendocrine liver metastases. Hepatogastroenterology 2000;47:481-6.
12. Yao KA, Talamonti MS, Nemcek A, Angelos P, Chrisman H, Skarda J, et al. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery 2001;130:677-85.
13. Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG. Surgical treatment of neuroendocrine metastases to the liver: A plea for resection to increase survival. J Am Coll Surg 2003;197:29-37.
14. Chung MH, Pisegna J, Spirt M, Giuliano AE, Ye W, Ramming KP, et al. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: A paradigm for intractable neuroendocrine tumors metastatic to the liver. Surgery 2001;130:954-62.
15. McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990;108:1091-6.
16. Carty SE, Jensen RT, Norton JA. Prospective study of aggressive resection of metastatic pancreatic endocrine tumors. Surgery 1992;112:1024-32.
17. Dousset B, Saint-Marc O, Pitre J, Soubrane O, Houssin D, Chapuis Y. Metastatic endocrine tumors: Medical treatment, surgical resection, or liver transplantation. World J Surg 1996;20:908-15.
18. Norton JA, Warren RS, Kelly MG, Zuraek MB, Jensen RT. Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery 2003;134:1057-65.
19. Solcia E, Kl_doppel G, Sobin LH. Histologic Typing of Endocrine Tumours. World Health Organization International Histological Classification of Tumours, 2nd edn. New York: Springer-Verlag Telos 2000.
20. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological Typing of Lung and Pleural Tumours. World Health Organization International Histological Classification of Tumours, 3rd edn. Berlin, Springer 1999.
21. Moertel CG. Karnofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol 1987;5:1503-22.
22. Thompson GB, van Heerden JA, Grant CS, Carney JA, Ilstrup DM. Islet cell carcinomas of the pancreas: A twenty-year experience. Surgery 1988;104:1011-17.
23. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-59.
24. Soga J. Carcinoid tumors: A statistical analysis of a Japanese series of 3,126 reported and 1,180 autopsy cases. Acta Med Biol 1994; 42:87-102.
25. Elias D, Lasser P, Ducreux M, Duvillard P, Ouellet JF, Dromain C, et al. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: A 15-year single center prospective study. Surgery 2003;133:375-82.
26. Boudreaux JP, Putty B, Frey DJ, Woltering E, Anthony L, Daly I, et al. Surgical treatment of advanced-stage carcinoid tumors: Lessons learned. Ann Surg 2005;241:839-46.
27. Sarmiento JM, Que FG. Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am 2003;12:231-42.
28. Osborne DA, Zervos EE, Strosberg J, Boe BA, Malafa M, Rosemurgy AS, et al. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. Ann Surg Oncol 2006;13:572-81.